Recent studies showed that this selectivity may be due to the difference in the expression level of lipid metabolism enzymes (such as ACSL4(1)) and REDOX homeostasis between tumor cells and normal cells, but the specific regulatory network still needs to be further elucidated [34]. This evidence concerns the gene ACSL4 and neoplasm.